The effect of repeated-dose activated charcoal on the pharmacokinetics of sodium valproate in healthy volunteers

被引:15
作者
AlShareef, A
Buss, DC
Shetty, HGM
Ali, N
Routledge, PA
机构
[1] UNIV WALES COLL MED,DEPT PHARMACOL,ACAD CTR,LLANDOUGH HOSP NHS TRUST,CARDIFF,S GLAM,WALES
[2] UNIV WALES COLL MED,DEPT THERAPEUT & TOXICOL,ACAD CTR,LLANDOUGH HOSP NHS TRUST,CARDIFF,S GLAM,WALES
[3] UNIV WALES COLL MED,SECT RESP MED,ACAD CTR,LLANDOUGH HOSP NHS TRUST,CARDIFF,S GLAM,WALES
关键词
charcoal; sodium valproate; pharmacokinetics;
D O I
10.1111/j.1365-2125.1997.tb00041.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims We investigated the effects of repeated-dose charcoal administered several hours after sodium valproate on the pharmacokinetics of a single dose of the drug in healthy volunteers. Methods The pharmacokinetics of sodium valproate were studied in seven healthy volunteers after administration of a syrup (300 mg) on two occasions, one of which was followed by administration of repeated doses of oral charcoal starting 4 h after the drug up to 32 h (total dose 80 g). Results Valproate was rapidly absorbed with maximum concentrations Ih after administration. The area under the plasma concentration-time curve to 48 h (AUG (0,48 h)) was 408 +/- 114.5 (s.d.) mg l(-1) h in the control phase and 398 +/- 108.6 mg l(-1) h after charcoal and the t(1/2) elimination was 20 +/- 6.8 h in the control phase, and 22 +/- 9.2 h after charcoal (NS). Conclusions Repeated-dose activated charcoal does not appear to enhance the rate of elimination of sodium valproate after therapeutic doses of the drug and any beneficial effect of charcoal in overdose may be to prevent absorption of valproate still present in the gut.
引用
收藏
页码:109 / 111
页数:3
相关论文
共 12 条
[1]   DRUG ADSORPTION TO CHARCOALS AND ANIONIC BINDING RESINS [J].
ALSHAREEF, AH ;
BUSS, DC ;
ROUTLEDGE, PA .
HUMAN & EXPERIMENTAL TOXICOLOGY, 1990, 9 (02) :95-97
[2]   FATALITY DUE TO MASSIVE OVERDOSE OF SODIUM VALPROATE [J].
CONNACHER, AA ;
MACNAB, MSP ;
MOODY, JP ;
JUNG, RT .
SCOTTISH MEDICAL JOURNAL, 1987, 32 (03) :85-86
[3]  
DICKINSON RG, 1980, J PHARMACOL EXP THER, V213, P38
[4]   CLINICAL PHARMACOKINETICS OF VALPROIC ACID [J].
GUGLER, R ;
UNRUH, GEV .
CLINICAL PHARMACOKINETICS, 1980, 5 (01) :67-83
[5]  
KLOTZ U, 1977, CLIN PHARMACOL THER, V21, P736
[6]  
MORROW JI, 1989, ADV DRUG REACT ACUTE, V8, P92
[7]   EFFECT OF ACTIVATED-CHARCOAL ON ABSORPTION OF TOLBUTAMIDE AND VALPROATE IN MAN [J].
NEUVONEN, PJ ;
KANNISTO, H ;
HIRVISALO, EL .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (02) :243-246
[8]   DISPOSITION OF SODIUM VALPROATE IN EPILEPTIC PATIENTS [J].
PERUCCA, E ;
GATTI, G ;
FRIGO, GM ;
CREMA, A ;
CALZETTI, S ;
VISINTINI, D .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 5 (06) :495-499
[9]  
PRESCOTT LFM, 3 WORLD C CLIN PHARM, P270
[10]  
TIFT JP, 1980, NEW ENGL J MED, V303, P394